Nicotine salt with meta-salicylic acid
US9724341B2 · kind B2 · utility
21Cited by
120References
2Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jul 11, 2014 |
| Grant date | Aug 8, 2017 |
| Priority date | — |
| Expiry date | Jul 11, 2034 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07C2601/16
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present disclosure relates generally to the field of nicotine delivery. The disclosure teaches a nicotine meta-salicylate. More specifically, the disclosure teaches a condensation nicotine aerosol where nicotine meta-salicylate is vaporized. This disclosure relates to aerosol nicotine delivery devices. The delivery devices can be activated by actuation mechanisms to vaporize thin films comprising a nicotine meta-salicylate. More particularly, this disclosure relates to thin films of nicotine salt with meta salicylic acid for the treatment of nicotine craving and for effecting smoking cessation.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.